Who is sponsoring NCT06005987?

NCT06005987 is sponsored by Carolyn Zahler-Miller.

What drugs are being tested in NCT06005987?

Interventions in NCT06005987: OneTouch Reveal application.

What condition does NCT06005987 study?

NCT06005987 studies Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes.

Is NCT06005987 still recruiting?

NCT06005987 is currently recruiting now. Last updated 31 January 2025.

Last reviewed 2025-01-31 · How we verify

NCT06005987

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mobile App Logging for Diabetes in Pregnancy

Recruiting now NA Last updated 31 January 2025

What this trial tests

NA trial testing OneTouch Reveal application in Gestational Diabetes Mellitus in Pregnancy in 40 participants. Currently enrolling.

Timeline

1 June 2024

Primary endpoint
1 January 2027

1 January 2027

Quick facts

Lead sponsor	Carolyn Zahler-Miller
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	40
Start date	1 June 2024
Primary completion	1 January 2027
Estimated completion	1 January 2027
Sites	1 location across United States

Drugs / interventions tested

OneTouch Reveal application

Conditions studied

Gestational Diabetes Mellitus in Pregnancy — all drugs for Gestational Diabetes Mellitus in Pregnancy →
Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

Carolyn Zahler-Miller

Who can join

Adults 18 to 100, female only, with Gestational Diabetes Mellitus in Pregnancy or Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Gestational Diabetes Mellitus in Pregnancy

Currently open trials in the same condition.

NCT05388643 — Early Detection of Gestational Diabetes Mellitus in Pregnancy · NA · recruiting
NCT06957028 — CGM for the Early Detection and Management of Hyperglycemia in Pregnancy · NA · recruiting
NCT06874907 — First Trimester Prediction of Gestational Diabetes Mellitus by Continuous Glucose Monitoring. · recruiting
NCT06802861 — Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclam · recruiting
NCT06548828 — Effects of a Non-nutritive Sweetener Reduction Intervention in Pregnancy and Lactation on Maternal and Infant Outcomes · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06005987 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carolyn Zahler-Miller
Last refreshed: 31 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06005987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing